Correlation Between Merck and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Merck and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Merck and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and NLS Pharmaceutics.
Diversification Opportunities for Merck and NLS Pharmaceutics
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Merck and NLS is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Merck i.e., Merck and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Merck and NLS Pharmaceutics
Considering the 90-day investment horizon Merck Company is expected to generate 0.14 times more return on investment than NLS Pharmaceutics. However, Merck Company is 7.34 times less risky than NLS Pharmaceutics. It trades about 0.01 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.04 per unit of risk. If you would invest 10,164 in Merck Company on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Merck Company or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Merck Company |
| NLS Pharmaceutics |
Merck and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and NLS Pharmaceutics
The main advantage of trading using opposite Merck and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.The idea behind Merck Company and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world |